SGLT2 inhibitors and lower limb complications: an updated meta‐analysis

BACKGROUND: To exam the associations between the use of sodium glucose co-transporter 2 inhibitor (SGLT2i) and the risk of lower limb complications, and to analyze the associated factors. METHODS: Pubmed, Medline, Embase, the Cochrane Center Register of Controlled Trials for Studies and Clinicaltria...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chu, Zhu, Xingyun, Cai, Xiaoling, Yang, Wenjia, Lv, Fang, Nie, Lin, Ji, Linong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082772/
https://www.ncbi.nlm.nih.gov/pubmed/33910574
http://dx.doi.org/10.1186/s12933-021-01276-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082772/
https://www.ncbi.nlm.nih.gov/pubmed/33910574
http://dx.doi.org/10.1186/s12933-021-01276-9

Ejemplares similares